FDA approves Bravecto Quantum (fluralaner), the first annual injection against fleas and ticks in dogs, offering 12 months of ...
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...
Bravecto Quantum’s active ingredient, fluralaner, is part of a class of antiparasitic drugs known as isoxazolines. Currently, several isoxazoline-based products are approved to treat and control fleas ...
BRAVECTO ® QUANTUM is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and for the treatment and control of tick infestations with Ixodes scapularis ...
KIRKLAND, QC, Oct. 2, 2025 /CNW/ -- Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), announced ...
AAVIO President Dr. Ravi Murarka underscored the association’s global outreach, highlighting the success of the Mission ...
Like Canada, this novel therapy would also be Europe’s first long-acting monoclonal antibody for pain relief associated with canine, if it is approved. Bedinvetmab injection was introduced to the ...
Winnie got her paws on the BARK x Crocs collab shoes for dogs. Here are some tips to get started. Don't forget to record your pup's first steps!
VetriScience's Composure treats contain L–theanine, Shoden Ashwagandha, and thiamine, wrapped in a peanut butter-flavored ...
A groundbreaking vaccine for Valley Fever in dogs could soon be available, with its release expected within the next year.
Certain dogs can not only memorize the names of objects like their favorite toys, but they can also extend those labels to entirely new objects with a similar function, regardless of whether or not ...
Crocs have become a worldwide phenomenon, with the company touting itself as "the world leader in innovative casual footwear," and humans aren't the only ones putting the foam resin shoes in "sport ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results